
RSC Advances p. 36039 - 36049 (2016)
Update date:2022-08-17
Topics:
Nguyen, Hanh T. H.
Nguyen, Oanh T. K.
Truong, Thanh
Phan, Nam T. S.
A crystalline porous copper-based metal-organic framework Cu-MOF-74 was synthesized, and was characterized by X-ray powder diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), Fourier transform infrared (FT-IR), atomic absorption spectrophotometry (AAS), and nitrogen physisorption measurements. The Cu-MOF-74 used was a recyclable catalyst for the condensation-cyclization reaction between 2-benzoyl pyridine and different benzylamines via oxidative amination of the C(sp3)-H bond to form 1,3-diarylated imidazo[1,5-a]pyridines using air as the oxidant. The Cu-MOF-74 exhibited better catalytic activity for the transformation than other MOFs including Cu(BDC), Cu2(BDC)2(DABCO), Cu3(BTC)2, Cu2(BPDC)2(BPY), Cu(OBA), Cu2(OBA)2(BPY), and Cu(INA)2. The solid catalyst could be recovered and reused several times without a significant degradation in catalytic activity. To the best of our knowledge, the synthesis of 1,3-diarylated imidazo[1,5-a]pyridines via oxidative amination of the C(sp3)-H bond was not previously performed under heterogeneous catalysis conditions.
View More
LinHai Cina Chemical Co., LTD.
Contact:0576-85580989
Address:Pharma-chem zone,Duqiao,Linhai,Zhejiang,China
Hubei Lingsheng Pharmaceuticals Co., Ltd.
Contact:+86-0710-3538058
Address:Xiangyang City Xiangcheng Economic Development Zone, Hubei Province
Cangzhou Senary Chemical Science-tech Co., Ltd
Contact:+86-317-3563899, 3563699
Address:168 Jinde Road, Cangzhou, Hebei, China
ShiJiaZhuang Dowell Chemical Co.,Ltd.
website:http://www.dowechem.com
Contact:+86-13463963265
Address:Xiyangling village, high tech Zone, Shijiazhuang,Hebei, China
Huaihua Baohua Biotechnology Co.,Ltd
website:http://www.baochengchem.com
Contact:86-519-82698291
Address:HouYang chemical development zone,Jintan,Jiangsu,China (213200)
Doi:10.1016/j.tet.2004.09.096
(2004)Doi:10.1016/j.tetasy.2010.03.021
(2010)Doi:10.1016/S0960-894X(02)00431-6
(2002)Doi:10.1016/j.steroids.2008.10.011
(2009)Doi:10.3109/14756366.2013.855926
(2014)Doi:10.1039/c39810000874
(1981)